Author: bonyf

bonyf is granted TFDA approval in Taiwan
Post

bonyf is granted TFDA approval in Taiwan

VADUZ, Liechtenstein, 13 February 2023 – To comply with new stringent regulations enforced in Taiwan for the sale of medical device products, bonyf has received the TFDA (Taiwan Food and Drug Administration) approval for 2 core products.

Inaugural shareholder newsletter released
Post

Inaugural shareholder newsletter released

GHENT, Belgium, 21 December 2022 – bonyf NV releases to its new shareholders the inaugural shareholder newsletter. The shareholder newsletter has been released by bonyf’s CEO and Founder, Mr Jean-Pierre Bogaert.

25% increase in turnover in H1 2022
Post

25% increase in turnover in H1 2022

Ghent (Belgium), 14 September, 2022, 6 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, announces a strong growth in turnover for the first half of 2022 ...

Annual results 2021
Post

Annual results 2021

Ghent (Belgium), 30 June, 2022, 7 p.m.; bonyf NV (ticker symbol: MLBON), the next-generation oral comfort expert, presents its 2021 financial statements, approved by ...